evidence: - COVID-19 vaccine approval (licensure) under a Biologics License Application (BLA) or authorization under an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) - CDC’s Emergency Use Instructions (EUI) for FDA-approved vaccines - The World Health Organization’s (WHO) Emergency Use Listing (EUL) or Prequalification of COVID-19 vaccines - ACIP’s General Best Practice Guidelines for Immunization [...] The 2024–2025 formulations for COVID-19 vaccines approved or authorized in the United States have been updated to a monovalent vaccine based on the Omicron JN.1-lineage of SARS-CoV-2, as follows: